Literature DB >> 23757314

Aberrant glycosylation of plasma proteins in severe preeclampsia promotes monocyte adhesion.

Shannon K Flood-Nichols1, Avedis A Kazanjian, Deborah Tinnemore, Philip R Gafken, Yuko Ogata, Peter G Napolitano, Jonathan D Stallings, Danielle L Ippolito.   

Abstract

Glycosylation of plasma proteins increases during pregnancy. Our objectives were to investigate an anti-inflammatory role of these proteins in normal pregnancies and determine whether aberrant protein glycosylation promotes monocyte adhesion in preeclampsia. Plasma was prospectively collected from nonpregnant controls and nulliparous patients in all 3 trimesters. Patients were divided into cohorts based on the applicable postpartum diagnosis. U937 monocytes were preconditioned with enzymatically deglycosylated plasma, and monocyte adhesion to endothelial cell monolayers was quantified by spectrophotometry. Plasma from nonpregnant controls, first trimester normotensives, and first trimester patients with mild preeclampsia inhibited monocyte-endothelial cell adhesion (P < .05), but plasma from first trimester patients with severe preeclampsia and second and third trimester normotensives did not. Deglycosylating plasma proteins significantly increased adhesion in all the cohorts. These results support a role of plasma glycoprotein interaction in monocyte-endothelial cell adhesion and could suggest a novel therapeutic target for severe preeclampsia.

Entities:  

Keywords:  adhesion; glycosylation; monocyte; pregnancy; severe preeclampsia

Mesh:

Substances:

Year:  2013        PMID: 23757314      PMCID: PMC3879990          DOI: 10.1177/1933719113492210

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  34 in total

Review 1.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

2.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

3.  A statistical model for identifying proteins by tandem mass spectrometry.

Authors:  Alexey I Nesvizhskii; Andrew Keller; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2003-09-01       Impact factor: 6.986

4.  TANDEM: matching proteins with tandem mass spectra.

Authors:  Robertson Craig; Ronald C Beavis
Journal:  Bioinformatics       Date:  2004-02-19       Impact factor: 6.937

5.  The complete amino acid sequence of alanine apolipoprotein (apoC-3), and apolipoprotein from human plasma very low density lipoproteins.

Authors:  H B Brewer; R Shulman; P Herbert; R Ronan; K Wehrly
Journal:  J Biol Chem       Date:  1974-08-10       Impact factor: 5.157

6.  Longitudinal analysis of maternal plasma apolipoproteins in pregnancy: a targeted proteomics approach.

Authors:  Shannon K Flood-Nichols; Deborah Tinnemore; Mark A Wingerd; Ali I Abu-Alya; Peter G Napolitano; Jonathan D Stallings; Danielle L Ippolito
Journal:  Mol Cell Proteomics       Date:  2012-10-10       Impact factor: 5.911

7.  Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion.

Authors:  Shenghe Cai; Alvin E Davis
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

Review 8.  Plasma lipoproteins: apolipoprotein structure and function.

Authors:  R W Mahley; T L Innerarity; S C Rall; K H Weisgraber
Journal:  J Lipid Res       Date:  1984-12-01       Impact factor: 5.922

9.  Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin.

Authors:  Charles J Dimitroff; Ralph J Bernacki; Robert Sackstein
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

10.  A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2.

Authors:  E K Moses; J A Lade; G Guo; A N Wilton; M Grehan; K Freed; A Borg; J D Terwilliger; R North; D W Cooper; S P Brennecke
Journal:  Am J Hum Genet       Date:  2000-10-17       Impact factor: 11.043

View more
  3 in total

1.  Relation of Serum and Salivary Total Sialic Acid and Total Sialic Acid/Total Protein Ratio with Clinical Parameters of Disease Progression in Preeclampsia.

Authors:  Jyothi M P D'souza; Vinitha Ramanath Pai; Sindhu Harish; Chitra Shriyan
Journal:  Indian J Clin Biochem       Date:  2021-01-27

2.  Integrated Proteomic and Metabolomic prediction of Term Preeclampsia.

Authors:  Ray Bahado-Singh; Liona C Poon; Ali Yilmaz; Argyro Syngelaki; Onur Turkoglu; Praveen Kumar; Joseph Kirma; Matthew Allos; Veronica Accurti; Jiansheng Li; Peng Zhao; Stewart F Graham; David R Cool; Kypros Nicolaides
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

3.  Glycoproteogenomics: A Frequent Gene Polymorphism Affects the Glycosylation Pattern of the Human Serum Fetuin/α-2-HS-Glycoprotein.

Authors:  Yu-Hsien Lin; Jing Zhu; Sander Meijer; Vojtech Franc; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2019-05-16       Impact factor: 5.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.